CSTL vs FLGT: stock comparison and AI forecast
Castle Biosciences Inc (CSTL) and Fulgent Genetics, Inc. (FLGT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CSTL Castle Biosciences Inc
- Market Cap
- $1.07B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
FLGT Fulgent Genetics, Inc.
- Price
- $19.29 +27.6% · 6M
- Market Cap
- $531M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- CSTL is 2.0 times larger than FLGT by market capitalization ($1.07B against $531M).
- CSTL turns -5.4% of its revenue into net income, against -26.1% for FLGT.
- CSTL carries 0.19 times debt per unit of equity, against 0.09 times for FLGT.
- Both companies share the SEC industry classification Services-Medical Laboratories.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CSTL | FLGT |
|---|---|---|
| Market Cap | $1.07B | $531M |
| P/B Ratio | 2.27x | 0.53x |
| EPS | $-1.05 | $-3.20 |
| Book Value/Share | $15.39 | $36.40 |
| Revenue/Share | $11.70 | $11.77 |
| FCF/Share | $-0.02 | $-3.77 |
Profitability & Margins
| Metric | CSTL | FLGT |
|---|---|---|
| ROE | -4.1% | -8.4% |
| ROA | -3.5% | -7.8% |
| ROIC | -6.4% | -12.0% |
| Gross Margin | 77.3% | 35.6% |
| Operating Margin | -9.0% | -37.8% |
| Net Margin | -5.4% | -26.1% |
| EBT Margin | -9.0% | -28.5% |
| Tax Rate | -0.7% | 7.5% |
Financial Health
| Metric | CSTL | FLGT |
|---|---|---|
| Current Ratio | 6.04x | 6.34x |
| Quick Ratio | 5.85x | 6.33x |
| D/E Ratio | 0.19x | 0.09x |
| Financial Leverage | 1.19x | 1.09x |
| Interest Coverage | -16.6x | -751.5x |
| Working Capital | $285M | $383M |
Cash Flow
| Metric | CSTL | FLGT |
|---|---|---|
| Operating Cash Flow | $43M | -$84M |
| Free Cash Flow | -$490K | -$104M |
| Capital Spending | -$43M | -$20M |
| OCF Growth YoY | -31.8% | – |
| FCF Growth YoY | -101.4% | – |
| FCF/Sales | -0.1% | -32.0% |
| CapEx/Sales | 12.1% | 6.2% |
Operational Efficiency
| Metric | CSTL | FLGT |
|---|---|---|
| Asset Turnover | 0.64x | 0.30x |
| Receivables Turnover | 7.4x | 5.0x |
| Inventory Turnover | 7.7x | 263.1x |
| Fixed Assets Turnover | 3.4x | 2.9x |
| Days Sales Outstanding | 49 days | 73 days |
| Days Inventory | 48 days | 1 days |
| Payables Period | 43 days | 27 days |
| Cash Conversion Cycle | 53 days | 47 days |
Income Statement
| Metric | CSTL | FLGT |
|---|---|---|
| Total Revenue | $357M | $324M |
| Operating Income | -$32M | -$122M |
| Net Income | -$19M | -$84M |
| R&D Expense | $55M | $57M |
| SG&A Expense | $244M | $244M |
| Cost of Goods Sold | $81M | $209M |
Dividend & Shareholder Information
| Metric | CSTL | FLGT |
|---|---|---|
| Shares Outstanding | 31M | 28M |
| EPS Growth | -328.3% | – |
CSTL vs FLGT: stock comparison and AI forecast
Which is bigger, CSTL or FLGT?
CSTL is 2.0 times larger than FLGT by market capitalization ($1.07B against $531M).
Which one does Intratio's AI model rank higher, CSTL or FLGT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.